FRONTEO Co., Ltd. (Headquarters: Minato-ku, Tokyo, President: Masahiro Morimoto, hereinafter referred to as FRONTEO) is a medical paper search AI system "Amanogawa" Okayama University Hospital Pharmacy Department (Location: Okayama City, Okayama Prefecture, Professor / Department of Pharmacy) : Yoshito Zamami).

　Amanogawais a medical paper search AI system equipped with FRONTEO's unique AI engine "Concept Encoder (trademark: conceptencoder, reading: concept encoder)".When researchers enter words, sentences, hypotheses, etc. they want to look up, AI^*Instantly detect related papers from the data of more than 2000 million papers published on . AI vector computing technology quantifies the meaning, relationships, and similarity of words and sentences, and analyzes search words and sentences based on their meanings and concepts, rather than matches as strings.This makes it possible to efficiently and exhaustively search for highly important information from a vast amount of information without bias due to the knowledge or perspective of the searcher.

Comment from Mr. Yoshito Zamami, Professor, Department of Pharmacy, Okayama University Hospital
“By using Amanogawa, we can greatly improve the efficiency of manuscript search and analysis work, which takes a lot of time for human work. increase."

Amanogawa system screen example. Space Map dots indicate individual papers.by article content
Clusters, annual transitions, lists of highly relevant papers, etc. can be grasped at a glance.

　FRONTEO will work on research and development to improve the quality of medical care and QOL of patients and contribute to the development of medicine and pharmacology through the provision of AI systems and the promotion of medical DX (digital transformation).

　The impact of this matter alone on the business results for the current fiscal year is minor, but we will promptly notify you if there are any matters to be disclosed.

* PubMed: A database of biomedical papers created by the National Center for Biological Sciences in the National Library of Medicine.

■ About Concept Encoder　URL:https://lifescience.fronteo.com/technology/conceptencoder/
"Concept Encoder" is a natural language analysis AI (artificial intelligence) developed by FRONTEO specializing in the life science field.It was developed in 2018 with the aim of effectively analyzing and utilizing medical data, including large amounts of free-form text data, based on evidence. "Concept Encoder" can also be co-analyzed with data other than text, and we are conducting research on co-analysis with numerical data such as gene expression information, vital signs, and various test values ​​that have been accumulated in the life science field.Patent registration number: Patent No. 6346367

■ About FRONTEO　URL:https://www.fronteo.com/
FRONTEO is a data analysis company that uses the in-house developed AI engines KIBIT and Concept Encoder, Looca Cross specialized in natural language processing to extract meaningful and significant information from a large amount of textual data and support companies' business. Since its inception in August 2003, we have been working globally with Japan, the United States, Korea, and Taiwan, mainly in the Legaltech business, such as e-discovery (electronic evidence disclosure) and digital forensic surveys, which support company international lawsuits. Based on AI technology developed in this project, we have expanded our business fields to life science, business intelligence, and economic security since 8, and have used AI to transform textual data into knowledge, thus contributing to the resolution of various companies' issues, including support for drug discovery, support for dementia diagnostics, and support for financial, human resources, and business. Listed on TSE Mothers (currently TSE Growth) on June 2014, 2007. In January 6, the company obtained a license to manufacture and sell Class I medical devices (license number: 26B2021X1), and in September of the same year, the company submitted a notification to sell controlled medical devices (notification number: 13MinatoMiSeikikiDai1). Capital: ¥10350 (as of March 9, 3).

※FRONTEO, Amanogawa, KIBIT, conceptencoder, Looca Cross are registered trademarks of FRONTEO.